Literature DB >> 18486714

Disorders involving calcium, phosphorus, and magnesium.

Sharon M Moe1.   

Abstract

Disorders of mineral metabolism are common in both the office and hospital setting. The diagnosis can be simplified by remembering the target organs involved--intestine, kidney, and bone--and by assessing the presence of kidney disease, levels of parathyroid hormone, and vitamin D status. Although the list of possible causes for these derangements is long, most patients who have hypercalcemia have hyperparathyroidism or malignancy; those who have hypocalcemia, hypophosphatemia, and hypomagnesemia have reduced gastrointestinal absorption, and those who have hyperphosphatemia and hypermagnesemia have increased intake in the setting of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486714      PMCID: PMC2486454          DOI: 10.1016/j.pop.2008.01.007

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  42 in total

Review 1.  Hyperparathyroid and hypoparathyroid disorders.

Authors:  S J Marx
Journal:  N Engl J Med       Date:  2000-12-21       Impact factor: 91.245

Review 2.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Bone Miner Res       Date:  2002-11       Impact factor: 6.741

3.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 4.  Use of intravenous magnesium to treat acute onset atrial fibrillation: a meta-analysis.

Authors:  Kwok M Ho; David J Sheridan; Timothy Paterson
Journal:  Heart       Date:  2007-04-20       Impact factor: 5.994

Review 5.  Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.

Authors:  Andrew F Stewart
Journal:  J Bone Miner Res       Date:  2002-05       Impact factor: 6.741

Review 6.  Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.

Authors:  L C Hofbauer; A E Heufelder
Journal:  J Mol Med (Berl)       Date:  2001-06       Impact factor: 4.599

Review 7.  Hypomagnesemia in acute and chronic illness.

Authors:  S Innerarity
Journal:  Crit Care Nurs Q       Date:  2000-08

Review 8.  The phosphatonin pathway: new insights in phosphate homeostasis.

Authors:  Susan C Schiavi; Rajiv Kumar
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

Review 9.  Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues.

Authors:  L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-07       Impact factor: 2.894

Review 10.  New lessons from old assays: parathyroid hormone (PTH), its receptors, and the potential biological relevance of PTH fragments.

Authors:  William G Goodman; Isidro B Salusky; Harald Jüppner
Journal:  Nephrol Dial Transplant       Date:  2002-10       Impact factor: 5.992

View more
  74 in total

Review 1.  Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-18       Impact factor: 4.052

2.  Ion-Selective Nanosensor for Photoacoustic and Fluorescence Imaging of Potassium.

Authors:  Chang H Lee; Jeff Folz; Wuliang Zhang; Janggun Jo; Joel W Y Tan; Xueding Wang; Raoul Kopelman
Journal:  Anal Chem       Date:  2017-07-12       Impact factor: 6.986

3.  Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.

Authors:  Cristina Garagarza; Ana Valente; Cristina Caetano; Telma Oliveira; Pedro Ponce; Ana Paula Silva
Journal:  Int Urol Nephrol       Date:  2017-03-06       Impact factor: 2.370

4.  Novel Risk Loci Identified in a Genome-Wide Association Study of Urolithiasis in a Japanese Population.

Authors:  Chizu Tanikawa; Yoichiro Kamatani; Chikashi Terao; Masayuki Usami; Atsushi Takahashi; Yukihide Momozawa; Kichiya Suzuki; Soichi Ogishima; Atsushi Shimizu; Mamoru Satoh; Keitaro Matsuo; Haruo Mikami; Mariko Naito; Kenji Wakai; Taiki Yamaji; Norie Sawada; Motoki Iwasaki; Shoichiro Tsugane; Kenjiro Kohri; Alan S L Yu; Takahiro Yasui; Yoshinori Murakami; Michiaki Kubo; Koichi Matsuda
Journal:  J Am Soc Nephrol       Date:  2019-04-11       Impact factor: 10.121

Review 5.  Drug-Induced Hypophosphatemia: Current Insights.

Authors:  Efstathia Megapanou; Matilda Florentin; Haralampos Milionis; Moses Elisaf; George Liamis
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

6.  Challenges in the differential diagnosis of hypercalcemia: A case of hypercalcemia with normal PTH level.

Authors:  Francesca Pellicciotti; Andrea Giusti; Maria Carolina Gelli; Salvatore Foderaro; Alberto Ferrari; Giulio Pioli
Journal:  World J Clin Oncol       Date:  2012-01-10

Review 7.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

8.  Multielement Determination in Medicinal Plants and Herbal Medicines Containing Cynara scolymus L., Harpagophytum procumbens D.C., and Maytenus ilifolia (Mart.) ex Reiss from Brazil Using ICP OES.

Authors:  Caroline de Aragão Tannus; Fernanda de Souza Dias; Filipe Barbosa Santana; Daniele Cristina Muniz Batista Dos Santos; Hemerson Iury Ferreira Magalhães; Fábio de Souza Dias; Aníbal de Freitas Santos Júnior
Journal:  Biol Trace Elem Res       Date:  2020-08-13       Impact factor: 3.738

9.  Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.

Authors:  Eun Sook Kim; Su Yeon Kim; Ji Young Lee; Je Ho Han; Tae Seo Sohn; Hyun Shik Son; Sung-Dae Moon
Journal:  J Bone Miner Metab       Date:  2015-09-19       Impact factor: 2.626

10.  Serum calcium and breast cancer risk in a prospective cohort study.

Authors:  Brian L Sprague; Halcyon G Skinner; Amy Trentham-Dietz; Kristine E Lee; Barbara E K Klein; Ronald Klein
Journal:  Ann Epidemiol       Date:  2010-01       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.